Johnson & Johnson (JNJ) Accounts Payables (2009 - 2026)
Johnson & Johnson (JNJ) reported Accounts Payables of $9.32 billion for Q3 2026, down 3.2% from $9.63 billion a year earlier but up 1.0% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Accounts Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Johnson & Johnson posted Accounts Payables of $11.99 billion, up 16.3% from FY2024.
- Accounts Payables has a four-year compound annual growth rate of 6.0% (FY2021 to FY2025).
- By year, Accounts Payables came in at $10.31 billion in FY2024 (+7.0%), $9.63 billion in FY2023 (-2.6%), $9.89 billion in FY2022 and $9.51 billion in FY2021.
- Five-year quarterly Accounts Payables spans a low of $8.17 billion in Q1 2024 and a high of $11.99 billion in Q4 2025.
- Year over year, Accounts Payables gained in six of the last eight quarters, with growth averaging 7.3%.
- The high point for year-over-year Accounts Payables in five years was Q1 2025 (growth of 16.8%); the low point was Q1 2024 (a decline of 17.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $9.22 billion (Q2 2026), $10.46 billion (Q1 2026) and $11.99 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - | - |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Vertex Pharmaceuticals | 141.76 Bn | 113.76 Bn | 2.84 Bn | 429.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 9.32 Bn |
| Jun 28, 2026 | 9.22 Bn |
| Mar 29, 2026 | 10.46 Bn |
| Dec 28, 2025 | 11.99 Bn |
| Sep 28, 2025 | 9.63 Bn |
| Jun 29, 2025 | 9.46 Bn |
| Mar 30, 2025 | 9.55 Bn |
| Dec 29, 2024 | 10.31 Bn |
| Sep 29, 2024 | 8.95 Bn |
| Jun 30, 2024 | 8.85 Bn |
| Mar 31, 2024 | 8.17 Bn |
| Dec 31, 2023 | 9.63 Bn |
| Oct 1, 2023 | 8.36 Bn |
| Jul 2, 2023 | 10.44 Bn |
| Apr 2, 2023 | 9.91 Bn |
| Jan 1, 2023 | 9.89 Bn |
| Oct 2, 2022 | 10.15 Bn |
| Jul 3, 2022 | 9.77 Bn |
| Apr 3, 2022 | 9.31 Bn |
| Jan 2, 2022 | 11.06 Bn |
API Access
Johnson & Johnson Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();